52 related articles for article (PubMed ID: 2081844)
1. [Post mortem HLA phenotyping of donors of eyes. Evaluation of a serological method of microlymphotoxicity on lymphocytes and PHA lymphoblasts].
Delbosc B; Urlacher A; Tongio MM; Flament J
J Fr Ophtalmol; 1990; 13(11-12):542-6. PubMed ID: 2081844
[TBL] [Abstract][Full Text] [Related]
2. Retinal pigment epithelial cells in post mortem HLA typing of corneal donors.
Baumgartner I; Asenbauer TT; Kaminski SL; Grabner G; Mayr WR
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1940-5. PubMed ID: 1582799
[TBL] [Abstract][Full Text] [Related]
3. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
4. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 activated lymphocytes show improved sensitivity for class 1 HLA typing.
Hirose M; Shinohara K; Watanabe H; Lee E; Kuroda Y
Tokushima J Exp Med; 1996 Dec; 43(3-4):87-91. PubMed ID: 9100455
[TBL] [Abstract][Full Text] [Related]
6. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
[TBL] [Abstract][Full Text] [Related]
7. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific sensitization by cadaveric venous allografts used for arterial reconstruction in peripheral arterial occlusive vascular disease.
Balzer KM; Luther B; Sandmann W; Wassmuth R
Tissue Antigens; 2004 Jul; 64(1):13-7. PubMed ID: 15191518
[TBL] [Abstract][Full Text] [Related]
9. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
[TBL] [Abstract][Full Text] [Related]
10. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients.
Oudshoorn M; Cornelissen JJ; Fibbe WE; de Graeff-Meeder ER; Lie JL; Schreuder GM; Sintnicolaas K; Willemze R; Vossen JM; van Rood JJ
Bone Marrow Transplant; 1997 Dec; 20(12):1011-7. PubMed ID: 9466272
[TBL] [Abstract][Full Text] [Related]
11. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
[TBL] [Abstract][Full Text] [Related]
12. [Expression of class I and class II markers on populations of leukemic cells].
Tongio MM; Falkenrodt A; Urlacher A; Mitsuishi Y; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard X; Mayer S
Pathol Biol (Paris); 1986 Jun; 34(6):753-7. PubMed ID: 3531991
[TBL] [Abstract][Full Text] [Related]
13. New strategies for selection of unrelated bone marrow donors.
Martinelli G; Buzzi M; Farabegoli P; Testoni N; Mantovani V; Calori E; Rosti G; Bandini G; Bragliani M; Panzica G
Bone Marrow Transplant; 1993; 11 Suppl 1():31-2. PubMed ID: 8448542
[TBL] [Abstract][Full Text] [Related]
14. [HLA typing of donor corneas with extended post mortem time].
Ventura AC; Böhnke M; Löliger C; Kühnl P; Winter R; Engelmann K
Ophthalmologe; 1996 Jun; 93(3):262-7. PubMed ID: 8753989
[TBL] [Abstract][Full Text] [Related]
15. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
16. The distribution of HLA antigens on human corneal tissue.
Whitsett CF; Stulting RD
Invest Ophthalmol Vis Sci; 1984 May; 25(5):519-24. PubMed ID: 6370904
[TBL] [Abstract][Full Text] [Related]
17. Ontogeny of the MHC antigens on human trophoblast cells during the first trimester of pregnancy.
Montgomery B; Lala PK
J Immunol; 1983 Nov; 131(5):2348-55. PubMed ID: 6415163
[TBL] [Abstract][Full Text] [Related]
18. [HLA typing in high risk keratoplasty].
Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
[TBL] [Abstract][Full Text] [Related]
19. [Application of the HLA system to forensic medicine--from serology to DNA polymorphism].
Kiuchi M
Nihon Hoigaku Zasshi; 2002 Sep; 56(2-3):229-35. PubMed ID: 12415830
[TBL] [Abstract][Full Text] [Related]
20. [Anti-HLA antibodies in nephropathic patients].
Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
